June 21, 2011
Sanofi-Aventis SA filed a suit Friday in New Jersey seeking to block Sun Pharmaceutical Industries Ltd. from launching a generic version of the French drugmaker's colorectal cancer treatment Eloxatin before August 2012 as provided under a license agreement between the parties.